These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3441450

  • 1. Effects of unilateral intracerebroventricular microinjections of cholecystokinin (CCK) on circling behavior of rats.
    Morency MA, Ross GM, Hesketh D, Mishra RK.
    Peptides; 1987; 8(6):989-95. PubMed ID: 3441450
    [Abstract] [Full Text] [Related]

  • 2. Role of leptin in the control of feeding of goldfish Carassius auratus: interactions with cholecystokinin, neuropeptide Y and orexin A, and modulation by fasting.
    Volkoff H, Eykelbosh AJ, Peter RE.
    Brain Res; 2003 May 16; 972(1-2):90-109. PubMed ID: 12711082
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Rotational syndrome after central injection of C-terminal 7-peptide of cholecystokinin.
    Mann JF, Boucher R, Schiller PW.
    Pharmacol Biochem Behav; 1980 Jul 16; 13(1):125-7. PubMed ID: 7190707
    [Abstract] [Full Text] [Related]

  • 5. Comparison of circling induced by unilateral intrastriatal microinjections of haloperidol, clozapine and CCK-8 in rats.
    Weiss F, Ettenberg A.
    Pharmacol Biochem Behav; 1986 Apr 16; 24(4):983-9. PubMed ID: 3012602
    [Abstract] [Full Text] [Related]

  • 6. Intracerebroventricular injection of cholecystokinin octapeptide elevates plasma prolactin levels through stimulation of vasoactive intestinal polypeptide.
    Tanimoto K, Tamminga CA, Chase TN, Nilaver G.
    Endocrinology; 1987 Jul 16; 121(1):127-32. PubMed ID: 3297634
    [Abstract] [Full Text] [Related]

  • 7. Cholecystokinin potentiates dopamine-mediated behaviors: evidence for modulation specific to a site of coexistence.
    Crawley JN, Stivers JA, Blumstein LK, Paul SM.
    J Neurosci; 1985 Aug 16; 5(8):1972-83. PubMed ID: 4040554
    [Abstract] [Full Text] [Related]

  • 8. Blocking of cholecystokinin octapeptide behavioral effects by proglumide.
    Katsuura G, Hsiao S, Itoh S.
    Peptides; 1984 Aug 16; 5(3):529-34. PubMed ID: 6089145
    [Abstract] [Full Text] [Related]

  • 9. Similar potencies of CCK-8 and its analogue BOC(Nle28;Nle31)CCK27-33 on the self-stimulation behaviour both are antagonized by a newly synthesized cyclic CCK analogue.
    Heidbreder C, Roques BP, De Witte P.
    Neuropeptides; 1989 Aug 16; 13(2):89-94. PubMed ID: 2739884
    [Abstract] [Full Text] [Related]

  • 10. A behavioural pharmacological study on intracerebroventricularly administered CCK-8 related peptides in mice.
    Hagino Y, Moroji T, Iizuka R.
    Neuropeptides; 1989 Aug 16; 13(2):107-13. PubMed ID: 2739882
    [Abstract] [Full Text] [Related]

  • 11. Preventive effect of cholecystokinin octapeptide on experimental amnesia in rats.
    Katsuura G, Itoh S.
    Peptides; 1986 Aug 16; 7(1):105-10. PubMed ID: 3714527
    [Abstract] [Full Text] [Related]

  • 12. Influence of cholecystokinin on central monoaminergic pathways.
    Widerlöv E, Kalivas PW, Lewis MH, Prange AJ, Breese GR.
    Regul Pept; 1983 May 16; 6(2):99-109. PubMed ID: 6308717
    [Abstract] [Full Text] [Related]

  • 13. Effects of amylin on feeding of goldfish: interactions with CCK.
    Thavanathan R, Volkoff H.
    Regul Pept; 2006 Jan 15; 133(1-3):90-6. PubMed ID: 16239037
    [Abstract] [Full Text] [Related]

  • 14. Balance of glutamate and dopamine in the nucleus accumbens modulates self-stimulation behavior after injection of cholecystokinin and neurotensin in the rat brain.
    Heidbreder C, Gewiss M, De Mot B, Mertens I, De Witte P.
    Peptides; 1992 Jan 15; 13(3):441-9. PubMed ID: 1523160
    [Abstract] [Full Text] [Related]

  • 15. Effects induced by BC 264, a selective agonist of CCK-B receptors, on morphine-dependent rats.
    Maldonado R, Valverde O, Derrien M, Tejedor-Real P, Roques BP.
    Pharmacol Biochem Behav; 1994 Jun 15; 48(2):363-9. PubMed ID: 8090802
    [Abstract] [Full Text] [Related]

  • 16. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1989 Dec 15; 36(6):881-6. PubMed ID: 2601685
    [Abstract] [Full Text] [Related]

  • 17. Modulation of passive avoidance behaviour of rats by intracerebroventricular administration of cholecystokinin octapeptide sulfate ester and nonsulfated cholecystokinin octapeptide.
    Kádár T, Fekete M, Telegdy G.
    Acta Physiol Acad Sci Hung; 1981 Dec 15; 58(4):269-74. PubMed ID: 6291322
    [Abstract] [Full Text] [Related]

  • 18. Evidence for dopaminomimetic effect of intrastriatally injected cholecystokinin octapeptide in mice.
    Worms P, Martinez J, Briet C, Castro B, Biziere K.
    Eur J Pharmacol; 1986 Mar 04; 121(3):395-401. PubMed ID: 3699101
    [Abstract] [Full Text] [Related]

  • 19. Opposite actions of CCK-8 on amphetamine-induced hyperlocomotion and stereotypy following intracerebroventricular and intra-accumbens injections in rats.
    Weiss F, Tanzer DJ, Ettenberg A.
    Pharmacol Biochem Behav; 1988 Jun 04; 30(2):309-17. PubMed ID: 3174761
    [Abstract] [Full Text] [Related]

  • 20. The behavioral effects of CCK8 injected into the medial nucleus accumbens are dependent on the motivational state of the rat.
    Daugé V, Dor A, Féger J, Roques BP.
    Eur J Pharmacol; 1989 Apr 12; 163(1):25-32. PubMed ID: 2744093
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.